Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.
Clostridium difficile infection is the most common hospital-acquired infection. Besides infected patients, carriers have emerged as a key player in C. difficile epidemiology. In this study, we evaluated the impact of identifying and isolating carriers upon hospital admission on the incidence of CDI incidence and hospital-acquired C. difficile colonization, as a single policy and as part of bundle approaches. We simulated C. difficile transmission using a stochastic mathematical approach, considering the contribution of carriers based on published literature. In the baseline scenario, CDI incidence was 6.18/1,000 admissions (95% CI, 5.72-6.65), simulating reported estimates from U.S. hospital discharges. The acquisition rate of C. difficile carriage was 9.72/1,000 admissions (95% CI, 9.15-10.31). Screening and isolation of colonized patients on admission to the hospital decreased CDI incidence to 4.99/1,000 admissions (95% CI, 4.59-5.42; relative reduction (RR) = 19.1%) and led to 36.2% reduction in the rate of hospital-acquired colonization. Simulating an antimicrobial stewardship program reduced CDI rate to 2.35/1,000 admissions (95% CI, 2.07-2.65). In sensitivity analysis, CDI incidence was less than 2.32/1,000 admissions (RR = 62.4%) in 95% of 1,000 simulations. The combined bundle, focusing on reducing C. difficile transmission from colonized patients and the individual risk of these patients to develop CDI, decreased significantly the incidence of both CDI and hospital-acquired colonization. Implementation of this bundle to current practice is expected to have an important impact in containing CDI.
Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.|School of Applied Mathematics and Physical Sciences, National Technical University of Athens, Athens, Greece.
Christos A
CA
Grigoras
Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Fainareti N
FN
Zervou
Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Ioannis M
IM
Zacharioudakis
School of Applied Mathematics and Physical Sciences, National Technical University of Athens, Athens, Greece.
Constantinos I
CI
Siettos
Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Eleftherios
E
Mylonakis
D000890:Anti-Infective Agents / Q000627:therapeutic use; D002353:Carrier State / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D016360:Clostridioides difficile / Q000302:isolation & purification*; D003015:Clostridium Infections / Q000175:diagnosis* / Q000453:epidemiology* / Q000517:prevention & control; D003428:Cross Infection / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D008962:Models, Theoretical; D010343:Patient Admission; D015995:Prevalence; D011336:Probability; D013269:Stochastic Processes
D000890:Anti-Infective Agents